Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

Throughout American history, there have been numerous attempts to assassinate sitting presidents, as well as president-elects and presidential candidates. The most recent came in summer 2024, when ...